Candida vulvovaginitis natural history, complications and prognosis: Difference between revisions
Ahmed Younes (talk | contribs) No edit summary |
Ahmed Younes (talk | contribs) |
||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
[[Candida Vulvovaginitis|Candida vulvovaginitis]] is a self limiting disease with no complications. [[Candida Vulvovaginitis|Candida vulvovaginitis]] is very responsive to local or oral [[antifungals]]. | |||
==Natural History== | ==Natural History== | ||
Revision as of 14:47, 1 May 2017
|
Candidiasis Main page |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Dima Nimri, M.D. [2]
Overview
Candida vulvovaginitis is a self limiting disease with no complications. Candida vulvovaginitis is very responsive to local or oral antifungals.
Natural History
Candida vulvovaginitis is a common infection of women in reproductive age group. Patients present with vulvar pruritus, dysuria, and vaginal discharge. Half of the affected patients have multiple episodes of the infection and less than 10% have recurrent infection.[1]
Prognosis
Candida albicans vulvovaginitis has excellent prognosis with azole therapy. Patients with non-Candida albicans infections are prone to have recurrence and treatment with boric acid and oral fluconazole has good prognosis.[2]
Complications
Candida vulvovaginitis is a self limiting disease with no complications.
References
- ↑ Fidel PL, Vazquez JA, Sobel JD (1999). "Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans". Clin Microbiol Rev. 12 (1): 80–96. PMC 88907. PMID 9880475.
- ↑ Fidel PL, Vazquez JA, Sobel JD (1999). "Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to C. albicans". Clin Microbiol Rev. 12 (1): 80–96. PMC 88907. PMID 9880475.